London-based Perceptic, which says its end-to-end AI platform for drug development is being used by top pharmaceuticals, raised a $12M seed led by Accel (Jeremy Kahn/Fortune)

Jeremy Kahn / Fortune: London-based Perceptic, which says its end-to-end AI platform for drug development is being used by top pharmaceuticals, raised a $12M seed led by Accel — A trio of former Palantir executives who helped spearhead that company's Life Sciences practice have founded a startup called Perceptic …